BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1906793)

  • 1. Endometrial vascular features prior to and following exposure to levonorgestrel.
    Hourihan HM; Sheppard BL; Belsey EM; Brosens IA
    Contraception; 1991 Apr; 43(4):375-85. PubMed ID: 1906793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphometric study of the human endometrium following continuous exposure to levonorgestrel released from vaginal rings during 90 days.
    Johannisson E; Brosens I; Cornillie F; Elder M; White J; Sheppard B; Hourihan H; d'Arcangues C; Belsey EM
    Contraception; 1991 Apr; 43(4):361-74. PubMed ID: 1906792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
    Au CL; Affandi B; Rogers PA
    Contraception; 1994 Nov; 50(5):477-89. PubMed ID: 7859456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial effects of levonorgestrel and estradiol: A Scanning electron microscopic study of the luminal epithelium.
    Nilsson O; Englund D; Weiner E; Victor A
    Contraception; 1980 Jul; 22(1):71-83. PubMed ID: 6774851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal enzymes in the human endometrium: a biochemical study in untreated and levonorgestrel-treated women.
    Cornillie F; Brosens I; Belsey EM; Marbaix E; Baudhuin P; Courtoy PJ
    Contraception; 1991 Apr; 43(4):387-400. PubMed ID: 1906794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin production in human endometrium following continuous exposure to low-dose levonorgestrel released from a vaginal ring.
    White JO; Sullivan MH; Patel L; Croxtall JD; d'Arcangues C; Belsey EM; Elder MG
    Contraception; 1991 Apr; 43(4):401-12. PubMed ID: 1649733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel.
    Landgren BM; Johannisson E; Xing S; Aedo AR; Diczfalusy E
    Contraception; 1985 Dec; 32(6):581-601. PubMed ID: 3937664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of levonorgestrel administered in large doses at different stages of the cycle on ovarian function and endometrial morphology.
    Landgren BM; Johannisson E; Aedo AR; Kumar A; Shi YE
    Contraception; 1989 Mar; 39(3):275-89. PubMed ID: 2496951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal study of changes in endometrial microvascular density in Norplant implant users.
    Hickey M; Simbar M; Young L; Markham R; Russell P; Fraser IS
    Contraception; 1999 Feb; 59(2):123-9. PubMed ID: 10361627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial angiogenic response in Norplant users.
    Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
    Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate.
    Landgren BM; Johannisson E; Masironi B; Diczfalusy E
    Contraception; 1982 Dec; 26(6):567-85. PubMed ID: 6820337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical study of endometrial microvascular basement membrane components in women using Norplant.
    Palmer JA; Lau TM; Hickey M; Simbah M; Rogers PA
    Hum Reprod; 1996 Oct; 11(10):2142-50. PubMed ID: 8943519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception.
    Subakir SB; Hadisaputra W; Siregar B; Irawati D; Santoso DI; Cornain S; Affandi B
    Hum Reprod; 1995 Oct; 10(10):2579-83. PubMed ID: 8567774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial vasculature in Norplant users.
    Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():45-50. PubMed ID: 8982745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
    Lau TM; Witjaksono J; Affandi B; Rogers PA
    Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of norethisterone enanthate on endometrial bleeding and changes in coagulation function, ovarian hormones and endometrial histology in Thai women.
    Meng YX; Virutamasen P
    Contraception; 1991 Jul; 44(1):73-82. PubMed ID: 1893702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A morphometric study of the effect of oral norethisterone or levonorgestrel on endometrial blood vessels.
    Hourihan HM; Sheppard BL; Bonnar J
    Contraception; 1986 Dec; 34(6):603-12. PubMed ID: 3103980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study.
    Hickey M; Fraser I; Dwarte D; Graham S
    Hum Reprod; 1996 Oct; 11 Suppl 2():35-44. PubMed ID: 8982744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.